|Articles|February 9, 2004
Imiquimod successfully treats multiple basal cell cancers
February 10- Imiquimod 5percent cream is effective for treating multiplesuperficial basal cell carcinomas, according to Michael Freeman, M.D., adermatologist at the Skin Center in Gold Coast, Australia."Imiquimod should be a revolutionary treatment for basal cell carcinoma,"said Dr. Freeman. "Patients who are shy of scalpels just love it."
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Nearly Half of Female Psoriasis Patients Report IPV, Study Finds
4
Dermatology Conferences and Meetings Calendar: December 2025
5














